To further determine whether PD-L1 was indispensable for MEF2A-mediated cetuximab sensitivity, sh-MEF2A and PD-L1 overexpression vector were co-transfected into CRC cells before cetuximab treatment. This evidence concerns the gene MEF2A and colorectal carcinoma.